Bas Vaessen
General Counsel bei EQT Life Sciences Group BV
Ursprung des Netzwerks ersten Grades von Bas Vaessen
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Erasmus University Rotterdam
105
| College/University | Other Consumer Services | 105 |
LSP Management Group BV
 LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies.
31
| Subsidiary | Investment Managers | 31 |
EQT Life Sciences Group BV
 EQT Life Sciences Group BV Investment ManagersFinance EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands.
22
| Subsidiary | Investment Managers | 22 |
| Public Company | Food: Specialty/Candy | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Bas Vaessen
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Amsterdam | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree | |
| University of Utrecht | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree President Graduate Degree Doctorate Degree | |
| University of Tilburg | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree Doctorate Degree | |
| Vrije Universiteit Amsterdam | College/University | Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| NIBC HOLDING N.V. | Investment Banks/Brokers | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
NIBC Bank NV
 NIBC Bank NV Finance/Rental/LeasingFinance NIBC Bank NV engages in the provision of investment banking and financial services. The firm offers advises on mergers, acquisitions, financial policy, and property financing, lending, leveraged finance, and derivatives. It provides asset financing to corporate lending, leveraged finance, oil and gas services, infrastructure, real estate, and shipping Sector. The company was founded in 1945 and is headquartered in The Hague, the Netherlands. | Finance/Rental/Leasing | Director/Board Member Director/Board Member Director/Board Member Private Equity Investor | |
| PHILIPS NV | Medical Specialties | Sales & Marketing Human Resources Officer Corporate Officer/Principal | |
LSP Advisory BV
 LSP Advisory BV Investment ManagersFinance Part of LSP Advisory Group BV, EQT Life Sciences is a healthcare investment firm based in Amsterdam, Netherlands. EQT Life Sciences has been connecting investors to inventors in the healthcare sector for over 30 years. The Dutch company has invested in close to two hundred private companies, raising billions of additional capital directed at supporting their R & D. EQT Life Sciences believes in fostering life and constant innovation in healthcare to achieve that goal. The company was founded in 1998, and Mark A. Wegter has been the CEO since then. Recently, EQT Life Sciences was acquired by EQT AB, one of the largest private equity firms in Europe, and among the top-ten private equity firms globally. | Investment Managers | Director/Board Member Chief Executive Officer Director/Board Member | |
ING Bank NV
 ING Bank NV Major BanksFinance ING Bank NV engages in the provision of banking, investment, life insurance, and retirement services. It operates through the following segments: Retail Netherlands, Retail Belgium, Retail Germany, Retail Other, Wholesale Banking, and Corporate Line Banking. The Retail Netherlands segment offers current and savings accounts, business lending, mortgages, and other consumer lending in the Netherlands. The Retail Belgium segment focuses in the retail and private banking activities in Belgium and offered services like the Netherland segment. The Retail Germany segment consists of current and savings accounts, mortgages, and other customer lending. The Retail Other segment comprises income from retail banking activities in the rest of the world, including the SME and mid-corporate segments. The Wholesale Banking segment include income from wholesale banking activities (a full range of products is offered from cash management to corporate finance), real estate, and lease. The Corporate Line Banking segment comprises corporate line banking and the run-off portfolio of Real Estate. The company was founded in 1991 and is headquartered in Amsterdam, the Netherlands. | Major Banks | Corporate Officer/Principal Chairman Public Communications Contact | |
| Nyenrode Business Universiteit | College/University | Graduate Degree Undergraduate Degree Corporate Officer/Principal | |
AlpInvest Partners BV
 AlpInvest Partners BV Investment ManagersFinance AlpInvest Partners BV (AlpInvest) is a private equity asset subsidiary AP BV, ultimately owned by The Carlyle Group, Inc founded in 2000. AlpInvest Partners BV is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor Public Communications Contact Corporate Officer/Principal | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of Leiden | College/University | Director/Board Member Undergraduate Degree Doctorate Degree | |
Intrexon ActoBiotics NV
 Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| CELYAD ONCOLOGY SA | Biotechnology | Director/Board Member Corporate Officer/Principal | |
KLM Jet Center
 KLM Jet Center Other TransportationTransportation KLM Jet Center provides aviation handling services. The company is headquartered in Rotterdam, the Netherlands. | Other Transportation | Director/Board Member Director/Board Member | |
PGGM Vermogensbeheer BV
 PGGM Vermogensbeheer BV Investment ManagersFinance PGGM Vermogensbeheer BV (PGGM) is a non-profit cooperative pension administration organization headquartered in Zeist, Netherlands. The firm was founded as a foundation in 2008. They are a wholly-owned subsidiary of PGGM NV, itself a subsidiary of PGGM Coöperatie. PGGM supports several pension funds for employees in the healthcare and welfare sectors, provides them with asset management, management support and policy advice. PGGM is a socially responsible investor which invests in companies that respect environmental, social and governance factors. | Investment Managers | Investment Committee Member Chief Investment Officer | |
Egle Therapeutics SAS
 Egle Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Egle Therapeutics SAS is a biotech company based in Paris, France. Egle Therapeutics develops first-in-class immunotherapies targeting immune suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases. The French company leverages its translational-based target discovery platform to unveil novel therapeutic Treg targets and computationally designed immunocytokines acting as antagonists or as selective Treg-agonists. The company was founded in 2020 by Luc Boblet, a serial biotech entrepreneur, and Dr. Eliane Piaggio, a renowned immunologist. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
AlpInvest US Holdings LLC
 AlpInvest US Holdings LLC Investment ManagersFinance AlpInvest Partners, Inc. (AlpInvest) is the New York City private equity subsidiary of Netherlands-based AlpInvest Partners BV, ultimately held by The Carlyle Group LP (NASDAQ: CG). Established in 1999 as NIB Capital Private Equity, the firm became AlpInvest Partners in 2004. They were the first exclusive private equity manager for a public pension fund and invest worldwide across primary funds, secondaries, and direct investment (co-investment) channels, covering the entire private equity spectrum. In addition to the New York office, AlpInvest has offices in Amsterdam, Hong Kong and London. They are a socially responsible investor which works to promote sustainability and governance as an important factor in investment choices. They are a signatory to the UN Principles for Responsible Investments and exclude direct investments in companies that are directly involved in the manufacturing or distribution of products that clearly violate Dutch and relevant international conventions. They also explore sustainability-themed investments. | Investment Managers | Chairman Investment Committee Member | |
| Rotterdam School of Management | College/University | Doctorate Degree Masters Business Admin | |
Het Concertgebouw NV
 Het Concertgebouw NV Movies/EntertainmentConsumer Services Het Concertgebouw NV provides bands, orchestra and music entertainment services. It offers purchase tickets, tours, categories and charts. The company was founded on July 8, 1882 and is headquartered in Amsterdam, the Netherlands. | Movies/Entertainment | Chairman Director/Board Member | |
| OCULIS HOLDING AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Groningen | College/University | Graduate Degree Doctorate Degree | |
| Delft University of Technology | College/University | Graduate Degree Graduate Degree | |
Dr. Reddy's Research & Development BV
 Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| Imperial College London | College/University | Doctorate Degree Doctorate Degree | |
Xilis, Inc.
 Xilis, Inc. Medical SpecialtiesHealth Technology Xilis, Inc. engages in the development of droplet-based microfluidics technology devices for precision cancer diagnostics and drug development. It offers Xilis platform. The company was founded by Xiling Shen and David Shu and is headquartered in Durham, NC. | Medical Specialties | Founder Director/Board Member | |
Neuravi Ltd.
 Neuravi Ltd. Medical SpecialtiesHealth Technology Neuravi Ltd. designs and develops medical devices for the treatment of acute stroke. Through its investment in the Neuravi Thromboembolic Initiative the company supports collaboration between engineers, clinicians and researchers to deepen the understanding of clot and occlusion dynamics to improve patient outcomes in stroke. Neuravi The company was founded by Mahmood K. Razav, Eamon Brady, John O'Shaughnessy and David Vale in 2009 and is headquartered in Galway, Ireland. | Medical Specialties | Director/Board Member Director/Board Member | |
The Royal Netherlands Academy of Arts & Sciences
 The Royal Netherlands Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Netherlands Academy of Arts & Sciences provides research services in the field of science and art. The private company is based in Amsterdam, Netherlands and has subsidiaries in Netherlands. The CEO of the Dutch company is Wilma de Koning. | Miscellaneous Commercial Services | President Director/Board Member | |
| ROLINCO N.V. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Chairman | |
McKinsey & Co., Inc. (Belgium)
 McKinsey & Co., Inc. (Belgium) Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consultancy services. It serves businesses, governments, non governmental organizations, and non-profit organizations. The company was founded by James O. McKinsey in 1926 and is headquartered in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Robeco Institutional Asset Management BV
 Robeco Institutional Asset Management BV Investment ManagersFinance Robeco Institutional Asset Management BV (RIAM) is the Netherlands-based asset management subsidiary of Robeco Europe NV, itself a subsidiary of ORIX Corp. (TYO: 8591, ADR: IX), a Japanese business conglomerate that started operations in 1964. Headquartered in Rotterdam, the firm was founded in 1929 and provides investment products and services to institutional and private clients through locations in Europe, the US, the Middle East and Asia. RIAM is a socially responsible investor which engages in active dialogue with the companies in which they invest about good corporate governance and subjects of environmental or social interest. Their product range encompasses fixed-income, equity and alternative investments. | Investment Managers | Chief Executive Officer Chairman | |
| Robeco Nederland BV | Chief Executive Officer Director/Board Member | ||
ViCentra BV
 ViCentra BV Electronic Equipment/InstrumentsElectronic Technology ViCentra BV engages in the development of medical devices. It focuses in creating devices for diabetes patients. The company was founded by Tim Oakes and Joseph John Cefai in 2013 and is headquartered in Utrecht, the Netherlands. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
| KLM ROYAL DUTCH AIRLINES | Airlines | Director/Board Member Director/Board Member | |
| NEXSTIM PLC | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
BMEYE BV
 BMEYE BV Electronic Equipment/InstrumentsElectronic Technology BMEYE BV operates as a non-invasive cardiovascular monitoring company. The firm manufactures and distributes non-invasive technology, hemodynamic monitoring equipment and related medical devices. It offers finger arterial pressure and cardiac output technologies. The company was founded in April 2005 and is headquartered in Amsterdam, the Netherlands. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
Health Economics Privak II NV
 Health Economics Privak II NV Finance/Rental/LeasingFinance Health Economics Privak II NV is a Belgian company that provides credit intermediation services. The private company is based in De Pinte, Belgium. The company was founded in 2017. | Finance/Rental/Leasing | Director/Board Member Director/Board Member | |
| University of Twente | College/University | Corporate Officer/Principal Graduate Degree | |
| ING BANK SLASKI S.A. | Regional Banks | Director/Board Member Director/Board Member | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
Vico Therapeutics BV
 Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member | |
MyCartis NV
 MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Biotechnology | Chairman Director/Board Member | |
| NASPERS LIMITED | Internet Software/Services | Director/Board Member Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Van Lanschot Kempen Investment Management NV
 Van Lanschot Kempen Investment Management NV Investment ManagersFinance Van Lanschot Kempen Investment Management NV (Van Lanschot Kempen) is a specialist wealth manager headquartered in Amsterdam, Netherlands. The firm was founded in 1991 and was formerly known as Kempen Capital Management NV. They are a wholly-owned subsidiary of Van Lanschot Kempen NV (AMS: VLK). Van Lanschot Kempen administers Dutch pension funds and provides integral asset management for Dutch institutional clients. | Investment Managers | Portfolio Manager-Equities Chief Executive Officer |
Statistik
International
| Niederlande | 34 |
| Belgien | 6 |
| Vereinigte Staaten | 4 |
| Frankreich | 3 |
| Schweiz | 3 |
Sektoral
| Consumer Services | 15 |
| Health Technology | 14 |
| Finance | 13 |
| Commercial Services | 4 |
| Transportation | 3 |
Operativ
| Director/Board Member | 358 |
| Chief Executive Officer | 177 |
| Corporate Officer/Principal | 139 |
| Private Equity Investor | 83 |
| Graduate Degree | 69 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Geert-Jan Schipper | 135 |
| Martijn Kleijwegt | 33 |
| Leni M. T. Boeren | 32 |
| Marjan Johanna Oudeman | 32 |
| Marieke Bax | 30 |
| René Kuijten | 30 |
| Rudy Dekeyser | 29 |
| Peter Paul F. de Vries | 23 |
| Helen Tveitan-de Jong | 22 |
| Angelien G. Z. Kemna | 21 |
| John Paul de Koning | 21 |
| Caspar Antonius Berendsen | 20 |
| Jeroen J. M. Kremers | 18 |
| Boudewijn Clemens Wentink | 16 |
| Anne Portwich | 16 |
- Börse
- Insiders
- Bas Vaessen
- Unternehmensverbindungen